193 related articles for article (PubMed ID: 26797933)
1. A case report of mantle cell lymphoma manifesting as a foot lesion.
Samarghandi A; Ahuja S; Gupta S; Fulger I; Katava G; Fang Y
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26797933
[TBL] [Abstract][Full Text] [Related]
2. What lies beneath: Cutaneous involvement of mantle cell lymphoma underlying an insect-bite-like reaction.
Shah RA; Powell PR; Parekh PK
J Cutan Pathol; 2021 Apr; 48(4):563-566. PubMed ID: 32776338
[TBL] [Abstract][Full Text] [Related]
3. Case Study: Rare Case of Mantle Cell Lymphoma With Extranodal Involvement in the Foot.
Fu P; Mercado D; Malezhik V; Mannan AASR
J Foot Ankle Surg; 2017; 56(5):1104-1108. PubMed ID: 28842094
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
7. [Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].
Matsuoka A; Tsushima T; Tanibuchi M; Katsuki N; Kushida Y; Takata K; Taoka T
Rinsho Ketsueki; 2013 Nov; 54(11):2056-61. PubMed ID: 24305539
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
Andhavarapu S; Crozier JA; Jiang L; Sher T
Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
[TBL] [Abstract][Full Text] [Related]
9. Skin manifestation of mantle cell lymphoma.
Motegi S; Okada E; Nagai Y; Tamura A; Ishikawa O
Eur J Dermatol; 2006; 16(4):435-8. PubMed ID: 16935806
[TBL] [Abstract][Full Text] [Related]
10. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature.
Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N
J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
12. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Rummel M; Kaiser U; Balser C; Stauch M; Brugger W; Welslau M; Niederle N; Losem C; Boeck HP; Weidmann E; von Gruenhagen U; Mueller L; Sandherr M; Hahn L; Vereshchagina J; Kauff F; Blau W; Hinke A; Barth J;
Lancet Oncol; 2016 Jan; 17(1):57-66. PubMed ID: 26655425
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Lamonica D; Graf DA; Munteanu MC; Czuczman MS
J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
[TBL] [Abstract][Full Text] [Related]
14. Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature.
Shaikh H; Jani P; Shah R; Bilimoria F; Uchin J; Mewawalla P
J Hematol; 2018 Jan; 7(1):38-42. PubMed ID: 32300410
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings.
Czuczman MS; Goy A; Lamonica D; Graf DA; Munteanu MC; van der Jagt RH
Ann Hematol; 2015 Dec; 94(12):2025-32. PubMed ID: 26411584
[TBL] [Abstract][Full Text] [Related]
16. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
[TBL] [Abstract][Full Text] [Related]
17. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.
Visco C; Finotto S; Zambello R; Paolini R; Menin A; Zanotti R; Zaja F; Semenzato G; Pizzolo G; D'Amore ES; Rodeghiero F
J Clin Oncol; 2013 Apr; 31(11):1442-9. PubMed ID: 23401442
[TBL] [Abstract][Full Text] [Related]
18. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
19. Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma.
Mollejo M; Lloret E; Solares J; Bergua JM; Mateo M; Piris MA
Am J Hematol; 1999 Dec; 62(4):242-6. PubMed ID: 10589081
[TBL] [Abstract][Full Text] [Related]
20. In situ mantle cell lymphoma in the nasopharynx.
Koletsa T; Markou K; Ouzounidou S; Tsiompanou F; Karkavelas G; Kostopoulos I
Head Neck; 2013 Nov; 35(11):E333-7. PubMed ID: 23280758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
